← Eichor
Condition: Acute Urticaria Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Acute Urticaria

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria
Phase 3 · 1 location(s) · Shandong New Time Pharmaceutical Co., LTD · NCT06819774Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
Phase 1/Phase 2 · 1 location(s) · Institute for Asthma and Allergy · NCT07046806Comparing Standard-Dose and High-Dose Cetirizine for Acute Urticaria
NA · 1 location(s) · University of Phayao · NCT07236372Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Tre
Phase 3 · 23 location(s) · Octapharma · NCT06361537(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Phase 2 · 42 location(s) · Cogent Biosciences, Inc. · NCT04996875
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.